MariMed Inc.
MRMD
$0.11
-$0.02-15.39%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.05% | 0.06% | 0.26% | 4.62% | 10.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.05% | 0.06% | 0.26% | 4.62% | 10.73% |
| Cost of Revenue | 0.21% | 6.32% | 21.83% | 8.43% | 16.81% |
| Gross Profit | -5.19% | -8.10% | -26.61% | -0.36% | 3.25% |
| SG&A Expenses | -5.45% | 10.51% | -5.99% | 11.49% | 25.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.05% | 8.00% | 10.49% | 9.60% | 20.23% |
| Operating Income | -1.99% | -135.11% | -151.20% | -48.53% | -67.12% |
| Income Before Tax | 25.10% | -750.50% | 66.22% | -276.17% | -176.38% |
| Income Tax Expenses | -20.21% | 67.51% | 872.10% | -85.32% | -55.52% |
| Earnings from Continuing Operations | 22.51% | -319.50% | 19.11% | 76.69% | -75.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 108.33% | -433.33% | 90.00% | -260.00% | 47.83% |
| Net Income | 23.14% | -320.03% | 19.32% | 76.26% | -72.34% |
| EBIT | -1.99% | -135.11% | -151.20% | -48.53% | -67.12% |
| EBITDA | 5.82% | -54.34% | -64.40% | -23.67% | -31.43% |
| EPS Basic | 25.00% | -308.57% | 20.37% | 76.32% | -62.96% |
| Normalized Basic EPS | 0.00% | -510.00% | -1,700.00% | -100.00% | -129.17% |
| EPS Diluted | 25.00% | -308.57% | 20.37% | 76.32% | -62.96% |
| Normalized Diluted EPS | 0.00% | -510.00% | -1,700.00% | -100.00% | -129.17% |
| Average Basic Shares Outstanding | 2.74% | 1.96% | 1.39% | 2.02% | 5.05% |
| Average Diluted Shares Outstanding | 2.74% | 1.96% | 1.39% | 2.02% | 5.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -2.95% | -- |